Noida
NOIDA, India, December 2, 2011 -
The project is North India's biggest mixed-use development & Spira, one of the towers is India's tallest mixed use development
Strategic location connects to the 45m wide Noida expressway, upcoming 8-lane Kalindi Kunj & the proposed Metro Station connecting to Jasola
Rising from the banks of meandering Yamuna, the project 0 kms from Delhi
After the successful launch of North India's tallest residential development, North Eye, Supertech Limited has announced the launch of yet another one of its kind, grandeur project, 'Supernova', which is North India's biggest mixed-use development spread across 5 million sq.
NOIDA, India, June 28, 2011 -
Jubilant Discovery Services Inc., Bedminster, New Jersey, a
Jubilant Life Sciences Company,announced today that it has
entered into a drug discovery alliance with Janssen Pharmaceutica
N.V., Beerse, Belgium, that will aim to deliver preclinical
candidates to Janssen. The alliance is set to span an initial
periodof 3 years and will focus on multiple targets in the
area of neuroscience.
NOIDA, India, April 20, 2011 - HCL Technologies Ltd.
NOIDA, India, March 16, 2011 - HCL Technologies is deeply saddened by the natural calamity and loss of
lives in Japan and offers its heartfelt prayers and support to this resilient
nation.
NOIDA, India, March 8, 2011 - Jubilant Life Sciences Ltd (formerly Jubilant Organosys Ltd)
an integrated Pharma and Life Sciences company and the largest Custom
Research & Manufacturing player out of India, announced today that it is
setting up a manufacturing plant for "2,3,5,6-Tetra Chloro Pyridine" (also
commercially known as Symtet/TCP) of 24,000 TPA capacity and Chlorinated
Pyridine derivatives of 5,000 TPA,in Special Economic Zone, at Bharuch,
Gujrat.
More News
- Vineet Nayar Becomes the FIRST Global Leader to be Presented With This Award by CeBIT, the World's Largest Trade Fair Showcasing ICT
- IIT Kharagpur Law School to Accept LSAT(R) and LSAT–India for LLB Program in IP Laws
- HCL Technologies Enters Into Multi Year end-to-end IT Infrastructure Management Engagement With Purdue Pharma L.P.
- Quarterly Revenues up by 21.5% YoY and 7.7% Sequentially
- Jubilant to Work With Endo Pharmaceuticals on Drug Development
- Jubilant Enters Research Collaboration With AstraZeneca